Skip to content

The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Healthy Humans. A Dose-response Study

The Effect of Sodium Nitrite on Renal Variables, Brachial and Central Blood Pressure in Healthy Humans. A Randomized, Cross Over, Placebo Controlled Dose-response Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02078908
Enrollment
12
Registered
2014-03-05
Start date
2013-09-30
Completion date
2014-06-30
Last updated
2014-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Central blood pressure, Peripheral (brachial) blood pressure, Renal variables, Vasoactive hormones, Pharmacology, Pharmacokinetics

Brief summary

The purpose of this study is to investigate the effect of different doses of sodium nitrite infusion in 12 healthy subjects. The effects on renal handling of nitrite, nitrate, sodium and water, plasma concentrations of vasoactive hormones, peripheral (brachial) and central blood pressure will be evaluated. Hypothesis Sodium nitrite infusion 1. increases urinary sodium excretion and renal filtration rate 2. lowers blood pressure, central as well as peripheral 3. affects vasoactive hormones 4. it is possible to establish a dose that affects the renal function with only minor effect on the blood pressure.

Detailed description

Background: Nitric oxide (NO) is an important vasodilating molecule with a very complex biochemistry and metabolism. NO is classically synthesized from L-arginin by endothelial nitric oxide synthase (eNOS) located in the endothelial cell lining. Several chronic cardiovascular diseases such as hypertension, chronic kidney disease and diabetes are accompanied by endothelial dysfunction and hence diminished synthesis of NO. NO is a very reactive molecule and direct investigation of its function are limited and it has mainly been investigated by inhibition of eNOS. Recent research has shown that sodium nitrite is readily converted to NO by enzymes in vivo. The effects of sodium nitrite on renal variables, vasoactive hormones and central blood pressure are previously unexamined. It is now possible to achieve serial estimations of the central aortic systolic pressure (CASP) by newly designed wrist born device. Hypothesis: 1. Sodium nitrite infusion increases the urinary sodium excretion and glomerular filtration rate (GFR) in a dose related manner. 2. Sodium nitrite infusion increases plasma levels of nitrite, nitrate, NO and cyclic guanosine monophosphate (cGMP) 3. Sodium nitrite infusion lowers the peripheral and central blood pressure 4. Renal clearance of nitrite is constant and not dose dependent 5. Sodium nitrite infusion affects vasoactive hormones 6. It is possible to establish a dose that affects the renal variables with only minor effect on the blood pressure. Purpose: The purpose of this study is to investigate the effects of sodium nitrite infusion on 1. Renal handling of nitrite, nitrate, sodium and water 2. Plasma concentrations of vasoactive hormones 3. Peripheral (brachial) blood pressure and CASP Design: 12 healthy subjects are recruited in this randomised, cross over, placebo controlled, single-blinded study. Each subject will attend to four examination days. Four days prior to each examination day subjects are given a standardized diet with a low level of nitrate and nitrite. On the evening before the examination day the subjects take a single dose of lithium carbonate 300 mg in order to measure lithium clearance. On the examination days subjects are receiving a two hour infusion of either placebo (isotonic sodium chloride) or one of three doses of sodium nitrite. During the four examination days each subject receives all treatments in random order. Perspectives: Knowledge regarding hemodynamic and renal dose-response relationship is essential, in order to carry out future planned studies of the nitrite-NO system, in hypertensive subjects and during simultaneous modulation of various enzyme systems, involved in the conversion of nitrite to NO. Increasing knowledge about the nitrite-NO system can contribute to changing the clinical practise of diagnostics and treatment of cardiovascular diseases.

Interventions

DRUGSodium nitrite, 40 micrograms/kg/hour

Continuous 2 hour infusion of sodium nitrite, 40 micrograms/kg/hour

DRUGSodium nitrite, 120 micrograms/kg/hour

Continuous 2 hour infusion of sodium nitrite, 120 micrograms/kg/hour

DRUGSodium nitrite, 240 micrograms/kg/hour

Continuous 2 hour infusion of sodium nitrite, 240 micrograms/kg/hour

DRUGPlacebo

Continuous 2 hour infusion of sodium chloride, 25 ml/hour

Sponsors

Erling Bjerregaard Pedersen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI 18,5-30 kg/m2 * Women must use safe contraception

Exclusion criteria

* Tobacco smoking, medicine or substance abuse * Weekly consumption of more than 21 standard drinks of alcohol for men and 14 standard drinks of alcohol for women (1 danish standard drink equals 12 grams of alcohol) * Medical treatment in the last 2 weeks except for contraception * Pregnancy or nursing * Diabetes mellitus * estimated glomerular filtration rate (eGFR) \< 60 ml/min * neoplasm * clinically significant heart, lung, liver, kidney, metabolic og neurologic disease * clinically significant findings in screening blood samples, urine sample or ECG * Office blood pressure \> 140/90 mmHg * Blood donation within 1 month of the first day of investigation

Design outcomes

Primary

MeasureTime frame
Fractional urinary sodium excretionOne day

Secondary

MeasureTime frameDescription
Nitrate clearanceOne day
Glomerular filtration rateOne dayMeasured by determent renal clearance of 51Cr-EDTA (51-chrome ethylenediaminetetraacetic acid) using constant infusing technique
Proximal sodium transportOne dayProximal sodium transport is estimated by lithium clearance
Free water clearanceOne day
Urinary excretion of cyclic guanosine monophosphate (cGMP)One day
Urinary excretion of epithelial sodium channels (ENaC)One day
Urinary excretion of water channels (aquaporin-2)One day
Plasma concentration of reninOne day
Nitrite clearanceOne day
Plasma concentration of aldosteroneOne day
Plasma concentration of atrial natriuretic peptide (ANP)One day
Plasma concentration of brain natriuretic peptide (BNP)One day
Plasma concentration of cyclic guanosine monophosphate (cGMP)One day
Plasma concentration of endothelinOne day
Plasma concentration of vasopressin (AVP, ADH)One day
Peripheral (brachial) blood pressureOne dayMeasured by oscillometric sphygmomanometer, Omron 705IT, Omron Matsusaka CO. Ltd.
Central aortic systolic blood pressure (CASP)One dayEstimated by tonometric pulse wave analysis. Device: BPro from HealthSTATS International, Singapore
Plasma concentration of angiotensin 2One day

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026